Results 161 to 170 of about 7,245,481 (315)
The absence of evidence is not the evidence of absence [PDF]
Silvia, Sánchez-Ramón +4 more
openaire +2 more sources
Design and analysis strategies for robust microbiome ageing research
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source
IL-33-induced neuroimmune regulation in depression: A narrative review from molecular mechanisms to therapeutic potential. [PDF]
Wang G, Zhang X, Duan G, Yuan S.
europepmc +1 more source
Reconstructing enzyme evolution by protein engineering
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler +2 more
wiley +1 more source
Factors affecting survival in patients with colorectal cancer: an umbrella review. [PDF]
Yu L +9 more
europepmc +1 more source
The evidence for evidence-based medicine
R, Imrie, D W, Ramey
openaire +2 more sources
Cancer progression is regulated by the dynamic matrix code of the tumor microenvironment, which influences cellular behavior and disease development. Importantly, matrix remodeling in three‐dimensional cancer models more accurately reflects in vivo conditions compared to conventional two‐dimensional systems.
Sylvia Mangani +3 more
wiley +1 more source
Serum lipid profile patterns in patients with oral cancer and oral potentially malignant disorders. [PDF]
Singh P +5 more
europepmc +1 more source
The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi +6 more
wiley +1 more source
Retraction: How to promote the balanced development of urban and rural China? Evidences from reallocating idle rural residential land of Zhejiang province, China. [PDF]
PLOS One Editors.
europepmc +1 more source

